During the past decade, Evangelisches Krankenhaus Bielefeld conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evangelisches Krankenhaus Bielefeld" #1 sponsor was "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials, followed by "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "MicroPort CRM" with 2 trials sponsored and "University Hospital, Essen" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelisches Krankenhaus Bielefeld" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator, "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Evangelisches Krankenhaus Bielefeld" are "Acute Ischemic Stroke" (2 trials), "Heart Failure" (2 trials), "Leukemia" (2 trials), "Lymphoma" (2 trials) and "Neuroblastoma" (2 trials). Many other conditions were trialed in "Evangelisches Krankenhaus Bielefeld" in a lesser frequency.

Most popular intervention types in "Evangelisches Krankenhaus Bielefeld" are "Drug" (20 trials), "Device" (8 trials), "Radiation" (6 trials), "Biological" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "autologous hematopoietic stem cell transplantation" (3 trials), "carboplatin" (3 trials), "cyclophosphamide" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Evangelisches Krankenhaus Bielefeld" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Evangelisches Krankenhaus Bielefeld". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Evangelisches Krankenhaus Bielefeld, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Evangelisches Krankenhaus Bielefeld, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".

Evangelisches Krankenhaus Bielefeld has several departments that took part in Clinical trials: "Ev.Krankenhaus Bielefeld gGmbH; Klinik für Innere Medizin und Geriatrie" - 3 trials, "Evangelisches Krankenhaus Bielefeld GmbH, Klinik für Kinder- und Jugendmedizin, Hämatologie und Onkologie" - 2 trials